Detalhe da pesquisa
1.
High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clin Genitourin Cancer
; 11(3): 283-289.e1, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23684421